Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,091 recruiting studies in this area right now.
By phase
- Not applicable4,197
- Phase 2597
- Phase 1409
- Phase 3325
- Phase 4251
- Phase 1/Phase 2246
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer223
- Endometrial Cancer205
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer110
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer77
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Kidney Cancer59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- AstraZeneca38
- University of Colorado, Denver38
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California350
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida102
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,091 total
- NCT04911491Recruiting
Breathing muscle training for people with kidney disease
This study tests whether training your breathing muscles can improve health in people with chronic kidney disease (stage 3–4). It may help how your body handles daily activity and circulation-related measurements, compared with usual care.
Aurora, ColoradoAges 50 years+ - NCT05621837Recruiting
Biomarker study to guide treatment for several advanced cancers
This study measures how strongly your immune system is being suppressed and uses that information to help personalize cancer treatment. It mainly looks at people with certain advanced cancers and needs tumor tissue and follow-up to check possible immune-related markers.
MilanAges 18–90 - NCT07158723Recruiting
Protein and PCOS study for women
This trial tests how eating different types of protein affects women with PCOS. It may help you understand how your body responds to plant versus animal protein.
Fayetteville, ArkansasAges 18–50 - NCT07159555Recruiting
Neurofilament levels in late preterm newborns
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
LiègeAges Up to 3 weeks - NCT07164183RecruitingPhase 3
Comparing two drugs for endometriosis pain relief
This study tests if a new drug called Indinol Forto works as well as the standard drug Visanne for reducing endometriosis-related pelvic pain. It is for women with surgically confirmed endometriosis who have regular cycles and moderate to severe pain.
Kazan'Ages 18–45 - NCT07160855RecruitingPhase 4
Adding letrozole to standard miscarriage treatment
This trial tests whether adding letrozole (a hormone pill) to misoprostol (a medicine to complete a miscarriage) works better than misoprostol alone for ending a missed miscarriage in early pregnancy. It aims to make the process safer and possibly faster.
Multan, Punjab ProvinceAges 18–45 - NCT07160504RecruitingPhase 4
Vaginal estrogen's effect on blood clotting in postmenopausal women
This trial tests if low-dose vaginal estrogen tablets affect blood clotting in postmenopausal women with vaginal atrophy. It includes women both with and without a past blood clot to see if the treatment is safe.
Aarhus NAges 50 years+ - NCT07159503Enrolling by invitation
Comparing two procedures for 2-4cm kidney stones
This trial compares two methods to remove kidney stones that are 2-4 cm in size: one uses a thin tube through a small cut in your back (VISOR), and the other uses a larger cut (PCNL). The goal is to see which approach works better and has fewer side effects.
Hangzhou, ZhejiangAges 18–80 - NCT07163611RecruitingPhase 2/Phase 3
Obinutuzumab for PLA2R antibodies in membranous nephropathy
This study is testing a drug called obinutuzumab to see if it can lower PLA2R antibodies in people with membranous nephropathy (a kidney disease). The goal is to reduce protein leakage in urine and improve kidney health.
NijmegenAges 18 years+ - NCT07159880Recruiting
Letrozole for ovulation induction in PCOS
This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.
São Paulo, São PauloAges 18–40 - NCT07157397Recruiting
Plant-based diet for nutrition on dialysis
This study tests if eating more plant-based foods can improve nutrition in people on peritoneal dialysis who are underweight or malnourished. Participants will follow a special diet plan and have regular health check-ups for 6 months.
Cheras, Kuala LumpurAges 18 years+ - NCT07161947Recruiting
Pregnancy diabetes study in Shanghai
This study follows pregnant women with different types of diabetes or at high risk for it. The goal is to understand how blood sugar changes during and after pregnancy and to improve care.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07157423RecruitingPhase 4
A study of a medicine for heavy bleeding after childbirth in India
This study tests a medicine called eptacog alfa to see if it is safe for women in India who have severe bleeding after giving birth. It is for women who did not get better with standard treatments to help the uterus contract.
Belagavi, KarnatakaAges 18 years+ - NCT07156578Enrolling by invitationPhase 2
Long-term bivamelagon for hypothalamic obesity
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
Aurora, ColoradoAges 12 years+ - NCT07156123Recruiting
Peritoneal dialysis catheter data study
This study collects information from people who use or will start using a specific type of peritoneal dialysis (PD) catheter made by Fresenius. It aims to learn more about how these catheters work in real life, which may help improve future care.
DortmundAges Any age - NCT07156253RecruitingPhase 1
Study of SYN818 with olaparib for advanced solid tumors
This trial is testing a new drug, SYN818, combined with olaparib for people with advanced solid tumors that have certain genetic changes (BRCA mutations or related DNA repair problems). It may be an option if you have ovarian or HER2-negative breast cancer and other treatments are no longer working.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05245227RecruitingPhase 3
Prevent heavy bleeding after birth with two medicines versus one
This study tests whether using two medicines at the same time after delivery works better than using one medicine to prevent early heavy bleeding. It may help reduce the chance of postpartum hemorrhage soon after birth.
Stony Brook, New YorkAges 18 years+ - NCT05647109Recruiting
Test tumor-like cell clusters to predict progesterone response
This study looks at small lab samples taken from early endometrial cancer to see how sensitive the tumor is to progesterone treatment. It may help doctors choose the safest treatment that preserves fertility and the uterus for the right patients.
Beijing, Beijing MunicipalityAges 17–45 - NCT06921746Recruiting
Urinary microbiome and metabolism changes in overactive bladder treatment
This study looks at how the bacteria and chemicals in your urine change when women receive treatment for overactive bladder. It may help researchers understand why some treatments work better for some people.
Ostrava, Moravian-Silesian RegionAges 18 years+ - NCT06956365Recruiting
Comparing two medicines for bleeding during c-section under general anesthesia
This trial compares two drugs, oxytocin and carbetocin, to see which one better controls blood pressure and heart rate changes during cesarean section surgery. Both medicines help the uterus contract after delivery to reduce bleeding.
Van, TuşbaAges 18–40 - NCT07153432Recruiting
Chronic kidney disease screening for at-risk adults
This study is a simple screening to check for early signs of chronic kidney disease. It aims to find kidney problems in people who are at higher risk due to age or other health conditions.
PragueAges 18 years+ - NCT07146854Recruiting
EndoForce Connector Study for Dialysis Graft Access
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Orangeburg, South CarolinaAges 18 years+ - NCT07148999RecruitingPhase 1/Phase 2
Personalized IVF decision support tool
This trial is testing a new computer tool to help personalize IVF treatment for women with infertility. It aims to help doctors make better decisions about your care.
Houston, TexasAges 20–50 - NCT07148154Recruiting
Non-invasive test for endometrial cancer screening
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
L'Hospitalet de Llobregat, BarcelonaAges 40 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,091 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,865 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.